Progress in antiangiogenic gene therapy
โ
Andrew L. Feldman; Steven K. Libutti
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 145 KB
๐ 2 views
## BACKGROUND. Because tumors require angiogenesis for growth, inhibiting angiogenesis is a promising strategy for treating cancer patients. Although numerous endogenous angiogenesis inhibitors have been discovered, the clinical evaluation of these agents has been hindered by high dose requirement